UV Protection Habits and Preferences in Patients With Distinct Cutaneous Immune‐Mediated Inflammatory Diseases
Photodermatology, Photoimmunology & Photomedicine · 2026
DOI: 10.1111/phpp.70084 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, 2026. Verfasst von Zita Álvarez-Bobillo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Miguel Servet University Hospital, IIS Aragón, Zaragoza, Spain. Hauptthemen laut MEDLINE: Ultraviolet Rays, Sunscreening Agents, Skin Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Achieving adequate UV protection can be particularly challenging in patients with cutaneous immune‐mediated inflammatory dermatoses (IMIDs), owing to the clinical characteristics and quality‐of‐life impact of these diseases.
Objectives
To compare the UV protection habits and preferences of patients with cutaneous IMIDs, specifically considering expert recommendations for these diseases.
Methods
This pilot cross‐sectional, observational and analytical cohort study recruited 120 participants (78 female, 42 male; mean age, 40.8 ± 15.39 years): 20 cases for each IMID (vitiligo, atopic dermatitis, alopecia areata, psoriasis and hidradenitis suppurativa) and 20 healthy controls. Study variables included eye and hair color, BMI, phototype, clinical severity scales for each IMID, the Dermatology Life Quality Index (DLQI) score and a study‐specific questionnaire on photoprotection preferences.
Results
Daily photoprotection was reported by 40% of participants, with highest adherence (55%) in vitiligo patients. Hat use was generally low (24.17%), except among alopecia areata patients (40%). Overall, 63.3% of participants reported no sunburn in the last year, and 95% used an SPF > 15. Cream was the most commonly used SPF format, followed by spray. Oral photoprotection was known by 33.3% of participants, with highest use reported by vitiligo patients (45%). Compliance with UV protection recommendations for their specific disease was highest among vitiligo patients (70%), but did not exceed 10% for any other IMID.
Conclusions
Educating patients with cutaneous IMIDs about appropriate UV protection, tailored to their specific skin disorder, treatments and preferences, is crucial to improve compliance and disease control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Miguel Servet University Hospital, IIS Aragón, Zaragoza, Spain.
- Faculty of medicine, University of Zaragoza, Zaragoza, Spain.
ORCID-Profile: Zita Álvarez-Bobillo, Tamara Gracia-Cazaña, Yolanda Gilaberte-Calzada
Zitieren
APA
Álvarez-Bobillo, Z., Barandika-Urrutia, I., Gracia-Cazaña, T., & Gilaberte-Calzada, Y. (2026). UV Protection Habits and Preferences in Patients With Distinct Cutaneous Immune‐Mediated Inflammatory Diseases. Photodermatology, Photoimmunology & Photomedicine. https://doi.org/10.1111/phpp.70084
Vancouver
Álvarez-Bobillo Z, Barandika-Urrutia I, Gracia-Cazaña T, Gilaberte-Calzada Y. UV Protection Habits and Preferences in Patients With Distinct Cutaneous Immune‐Mediated Inflammatory Diseases. Photodermatology, Photoimmunology & Photomedicine. 2026. doi:10.1111/phpp.70084
BibTeX
@article{lvarezBobillo2026,
author = {Álvarez-Bobillo, Zita and Barandika-Urrutia, Iranzu and Gracia-Cazaña, Tamara and Gilaberte-Calzada, Yolanda},
title = {UV Protection Habits and Preferences in Patients With Distinct Cutaneous Immune‐Mediated Inflammatory Diseases},
journal = {Photodermatology, Photoimmunology & Photomedicine},
year = {2026},
doi = {10.1111/phpp.70084}
}
EUVIMED